Literature DB >> 31890819

Data for high-throughput screening of enzyme mutants by comparison of their activity ratios to an enzyme tag.

Yaping Li1, Huimin Chong1, Xiang Zhang1, Xiaolan Yang1, Fei Liao1,2.   

Abstract

Data in this article are associated with the research article "High-throughput screening of enzyme mutants by comparison of their activity ratios to an enzyme tag" (Li et al., 2019) [1]. Data are provided on the development of a system for high-throughput (HTP) screening of mutants through the comparison of the activity ratios of an applicable enzyme and its mutants to a suitable tag enzyme in cell lysates of their fused forms, with Escherichia coli alkaline phosphatase (ECAP) as the tag fused to the N-terminus of Pseudomonas Aeruginosa arylsulfatase (PAAS) and its mutants via a flexible linker. Data were made publicly available for further analyses.
© 2019 The Authors.

Entities:  

Keywords:  Activity ratio; Enzyme tag; Fusion expression; HTP screening; Mutant libraries

Year:  2019        PMID: 31890819      PMCID: PMC6931123          DOI: 10.1016/j.dib.2019.104985

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specifications Table The dataset in this report will facilitate understanding the validation and application of a new high-throughput screening strategy to mutants of an enzyme in a library [1]. To recognize positive mutants in a library, this new screening strategy fuses enzyme/mutants with a tag enzyme to compare activity ratios of the enzyme/mutants to the tag enzyme in cell lysates of their fused forms, when such activity ratios have physical significance and are proportional to specific activities of the non-fused counterpart enzyme/mutants. Re-analyses of these data will benefit researchers to develop a practical system of the new high-throughput screening strategy for directed evolution of an applicable enzyme. The data in this report utilizes Escherichia coli alkaline phosphatase (ECAP) as the tag enzyme for fusion with Pseudomonas Aeruginosa arylsulfatase (PAAS) via a flexible linker. Through the analyses of the data of the activities of ECAP in lysates of both Escherichia coli BL21 (DE3) transformed with a blank plasmid and host cells transformed with the fused mutants of PAAS, a rational threshold of ECAP activities in cell lysates can be developed for physical significance of the activity ratios of their fused forms at a preset confidence limit. Meanwhile, with a focused library of PAAS mutants through saturated mutagenesis at M72, the data enable researchers to understand the proportionality between the activity ratios of PAAS/mutants to ECAP in cell lysates of their fused forms and specific activities of the non-fused counterpart PAAS/mutants. The data in this report will provide insights on the application of the new screening strategy to the elucidation of sequence-activity relationship of an applicable enzyme.

Data description

The data in this article provides information on how to develop an experimental system for HTP screening of mutants through the comparison of the activity ratios of an applicable enzyme and its mutants to a suitable enzyme tag in cell lysates of their fused forms (Fig. 1, Fig. 2, Fig. 3, Fig. 4 and Table 1, Table 2, Table 3, Table 4, Table 5, Table 6, Table 7). Data supported validity of the proposed strategy and the advantage to recognize the positive mutant in each pair of PAAS/mutants during HTP screening and elucidate the sequence-activity relationship of PAAS in HTP mode (Fig. 5) (see Scheme 1).
Fig. 1

Three designed linkers for fusion expression of ECAP and PAAS.

Fig. 2

PAGE analyses of fragmentation patterns. Based on the Western blotting with polyclonal antibodies against PAAS, ECAP, monoclonal antibody against 6His tag, and Coomassie Blue R250 staining of polypeptides after SDS-PAGE in Fig. 1a, b, c, d in Ref. [1], respectively, here are the detection of polypeptides after separation by PAGE. (a) Coomassie Blue R250 staining. (b) ECAP activity staining with 1-Naphthol phosphate. (c) PAAS activity staining with 4-Nitrophenylsulfate on the same gel used in (b) after staining of ECAP activities.

Fig. 3

Distributions of PAAS mutants after saturation mutagenesis at M72. * represents the three termination codes.

Fig. 4

Association of activity ratios of the fused forms in cell lysates with specific activities of their purified non-fused counterparts.

Table 1

Thresholds of ECAP activities in cell lysates. Data for 140 individual clones transformed with the blank plasmid.

PNS (405 nm)
4NNPP (450 nm)
Activity Ratioa
ΔA/minAfter correction ΔA/minActivity on 4NPS (U/L)ΔA/minAfter correction ΔA/minActivity on 4NNPP (U/L)
−0.00184−0.00181−1.570.000500.000850.47−3.36
−0.00165−0.00163−1.420.000450.000770.42−3.34
−0.00112−0.00109−0.950.000500.000710.39−2.41
−0.00113−0.00110−0.960.000450.000670.37−2.59
−0.00076−0.00073−0.640.000500.000640.36−1.79
−0.00183−0.00181−1.570.000290.000640.35−4.47
−0.00118−0.00116−1.010.000400.000620.34−2.92
−0.00106−0.00104−0.900.000390.000590.33−2.77
−0.00100−0.00098−0.850.000390.000580.32−2.65
−0.00131−0.00129−1.120.000330.000580.32−3.53
−0.00104−0.00102−0.880.000350.000540.30−2.95
−0.00117−0.00116−1.000.000300.000520.29−3.48
−0.00122−0.00120−1.040.000290.000520.29−3.63
−0.00112−0.00110−0.960.000310.000520.29−3.32
−0.00077−0.00075−0.650.000370.000520.29−2.28
−0.00087−0.00085−0.740.000350.000510.28−2.63
−0.00110−0.00108−0.940.000300.000510.28−3.35
−0.00098−0.00096−0.840.000320.000500.28−3.01
−0.00115−0.00114−0.990.000280.000500.28−3.58
−0.00089−0.00087−0.760.000330.000500.27−2.77
−0.00088−0.00086−0.750.000330.000490.27−2.75
−0.00056−0.00054−0.470.000380.000490.27−1.74
−0.00082−0.00080−0.690.000330.000480.27−2.61
−0.00109−0.00108−0.940.000260.000470.26−3.60
−0.00107−0.00106−0.920.000260.000470.26−3.57
−0.00091−0.00089−0.780.000290.000460.26−3.03
−0.00110−0.00109−0.940.000250.000460.26−3.69
−0.00047−0.00045−0.390.000370.000460.26−1.54
−0.00011−0.00008−0.070.000440.000460.25−0.29
−0.00102−0.00100−0.870.000260.000460.25−3.46
−0.00064−0.00062−0.540.000330.000450.25−2.17
−0.00083−0.00081−0.700.000290.000450.25−2.85
−0.00063−0.00061−0.530.000320.000440.24−2.19
−0.00101−0.00099−0.860.000250.000440.24−3.59
−0.00105−0.00104−0.900.000240.000440.24−3.76
−0.00028−0.00026−0.230.000380.000440.24−0.94
−0.00038−0.00036−0.310.000350.000430.24−1.33
−0.00036−0.00034−0.300.000350.000420.23−1.27
−0.00074−0.00072−0.630.000280.000420.23−2.69
−0.00049−0.00047−0.410.000330.000420.23−1.77
−0.00038−0.00036−0.310.000350.000420.23−1.36
−0.00080−0.00078−0.680.000260.000420.23−2.97
−0.00068−0.00067−0.580.000280.000410.23−2.55
−0.00063−0.00061−0.530.000290.000410.23−2.34
−0.00048−0.00046−0.400.000320.000410.23−1.78
−0.00078−0.00077−0.670.000250.000390.22−3.07
−0.00105−0.00104−0.910.000190.000390.22−4.20
−0.00100−0.00099−0.860.000190.000380.21−4.09
−0.00071−0.00069−0.600.000250.000380.21−2.88
−0.00074−0.00072−0.630.000240.000380.21−3.03
−0.00131−0.00130−1.130.000130.000380.21−5.46
−0.00110−0.00109−0.950.000160.000370.21−4.62
−0.00043−0.00041−0.360.000290.000370.21−1.74
−0.00099−0.00098−0.850.000180.000370.20−4.18
−0.00058−0.00057−0.490.000250.000360.20−2.45
−0.00066−0.00065−0.570.000240.000360.20−2.83
−0.00034−0.00032−0.280.000290.000350.20−1.42
−0.00072−0.00071−0.610.000220.000350.20−3.14
−0.00060−0.00059−0.510.000240.000350.19−2.64
−0.00052−0.00050−0.440.000250.000340.19−2.31
−0.00045−0.00044−0.380.000250.000340.19−2.03
−0.00074−0.00072−0.630.000200.000340.19−3.36
−0.00076−0.00075−0.650.000190.000340.19−3.53
−0.00073−0.00072−0.620.000190.000330.18−3.43
−0.00048−0.00047−0.410.000240.000330.18−2.25
−0.00067−0.00066−0.580.000190.000320.18−3.27
−0.00037−0.00036−0.310.000250.000320.17−1.78
−0.00037−0.00036−0.310.000250.000320.17−1.78
−0.00022−0.00020−0.180.000270.000310.17−1.01
−0.00025−0.00024−0.210.000260.000310.17−1.21
−0.00054−0.00052−0.460.000210.000310.17−2.66
−0.00052−0.00051−0.440.000210.000310.17−2.59
−0.00050−0.00049−0.420.000210.000300.17−2.53
−0.00035−0.00034−0.300.000240.000300.17−1.77
−0.00085−0.00085−0.740.000140.000300.16−4.47
−0.00065−0.00064−0.560.000170.000300.16−3.42
−0.00045−0.00044−0.380.000210.000300.16−2.36
−0.00029−0.00028−0.240.000240.000290.16−1.50
−0.00034−0.00032−0.280.000230.000290.16−1.75
−0.00040−0.00039−0.340.000210.000280.16−2.14
−0.00020−0.00019−0.160.000250.000280.16−1.03
−0.00028−0.00027−0.230.000230.000280.16−1.51
−0.00033−0.00031−0.270.000220.000280.15−1.77
−0.00037−0.00036−0.310.000210.000280.15−2.03
−0.00055−0.00054−0.470.000170.000280.15−3.09
−0.00035−0.00034−0.300.000210.000280.15−1.95
−0.00015−0.00014−0.120.000250.000270.15−0.80
−0.00005−0.00003−0.030.000260.000270.15−0.17
−0.00009−0.00008−0.070.000250.000270.15−0.44
−0.00033−0.00032−0.270.000210.000270.15−1.83
−0.00013−0.00011−0.100.000250.000270.15−0.66
−0.00051−0.00050−0.430.000170.000270.15−2.92
−0.00012−0.00010−0.090.000250.000270.15−0.61
−0.00045−0.00043−0.380.000180.000270.15−2.57
−0.00045−0.00043−0.380.000180.000270.15−2.57
−0.00053−0.00052−0.450.000160.000260.15−3.09
−0.00047−0.00046−0.400.000170.000260.14−2.78
−0.00055−0.00055−0.470.000150.000260.14−3.31
−0.00029−0.00028−0.240.000200.000260.14−1.72
−0.00029−0.00028−0.240.000200.000260.14−1.72
−0.00037−0.00036−0.310.000180.000250.14−2.26
−0.00016−0.00015−0.130.000220.000250.14−0.95
−0.00021−0.00020−0.170.000210.000250.14−1.25
−0.00025−0.00024−0.210.000200.000250.14−1.54
−0.00010−0.00009−0.080.000230.000250.14−0.55
−0.00056−0.00056−0.480.000140.000240.13−3.60
−0.00031−0.00030−0.260.000180.000240.13−1.95
−0.00040−0.00039−0.340.000160.000240.13−2.57
−0.00015−0.00014−0.120.000210.000240.13−0.94
−0.00025−0.00023−0.200.000180.000230.13−1.62
−0.00062−0.00061−0.530.000110.000230.12−4.26
−0.00047−0.00046−0.400.000140.000230.12−3.24
−0.00046−0.00046−0.400.000140.000220.12−3.20
−0.00026−0.00025−0.220.000170.000220.12−1.79
−0.00035−0.00035−0.300.000150.000220.12−2.45
−0.00011−0.00010−0.090.000190.000210.12−0.73
−0.00010−0.00009−0.080.000190.000210.12−0.67
−0.00053−0.00052−0.450.000110.000210.12−3.92
−0.00035−0.00035−0.300.000140.000200.11−2.68
−0.00033−0.00032−0.280.000140.000200.11−2.53
−0.00051−0.00050−0.440.000100.000200.11−4.03
−0.00045−0.00045−0.390.000110.000200.11−3.61
−0.00003−0.00002−0.010.000180.000190.10−0.14
−0.000010.000000.000.000180.000180.100.01
−0.00015−0.00014−0.120.000150.000180.10−1.18
−0.00045−0.00044−0.380.000090.000180.10−3.95
−0.00018−0.00017−0.150.000140.000170.09−1.60
0.000210.000220.190.000210.000170.092.06
−0.00022−0.00021−0.180.000130.000170.09−1.97
−0.00014−0.00013−0.110.000130.000150.08−1.33
−0.00005−0.00005−0.040.000140.000150.08−0.50
−0.00004−0.00003−0.020.000140.000140.08−0.31
−0.00047−0.00047−0.410.000050.000130.07−5.48
−0.00031−0.00030−0.270.000070.000130.07−3.66
0.000040.000040.040.000140.000130.070.54
0.000470.000480.420.000180.000090.058.24
0.000560.000570.500.000190.000080.0510.74
−0.00015−0.00014−0.120.000050.000070.04−3.08
0.000730.000740.640.000160.000030.0144.67
0.000550.000560.480.00005−0.00006−0.03−14.73

Activity ratio was the activity of PAAS/mutant to that of ECAP in their fused form.

Table 2

Activity ratios of three fused forms via different linkers.

Activity by SSAb
Activity by SDESAc
Activity on 4NPS (kU/g)Activity on 4NNPP (kU/g)Activity RatioaActivity on 4NPS (kU/g)Activity on 4NNPP (kU/g)Activity Ratioa
Cell lysate (n = 3)
ECAP-dHis-PAAS2.17 ± 0.5320.36 ± 0.0826.01 ± 0.5972.04 ± 0.4150.34 ± 0.0726.07 ± 0.522
ECAP-LHis-PAAS2.50 ± 0.6220.40 ± 0.0766.27 ± 0.7102.55 ± 0.4300.40 ± 0.0916.39 ± 0.403
ECAP-LL-PAAS2.28 ± 0.5670.36 ± 0.0776.25 ± 0.6212.64 ± 0.3970.43 ± 0.0776.10 ± 0.389
Purified enzyme (n = 3)
ECAP-dHis-PAAS13.57 ± 3.022.22 ± 0.4706.11 ± 0.45712.67 ± 1.892.05 ± 0.4026.17 ± 0.321
ECAP-LHis-PAAS13.33 ± 2.162.14 ± 0.3896.24 ± 0.39712.00 ± 2.7851.85 ± 0.57756.47 ± 0.774
ECAP-LL-PAAS12.73 ± 2.032.03 ± 0.4216.29 ± 0.68712.54 ± 2.5742.00 ± 0.5106.26 0.440

Activities were determined by SSA/SDESA, with proteins quantified by Bradford method, activity ratio was the activity of PAAS/mutant to that of ECAP in their fused form.

SSA indicates separate single assay, one-by-one, in two solution.

SDESA indicates spectrophotometric-dual-enzyme-simultaneous-assay.

Table 3

Comparison of two methods for cell lysis.

MutantsaAlkline lysis (n = 6)
Sonication treatment (n = 6)
PNS/4NNPPRelative valuebPNS/4NNPPRelative valueb
ECAP-PAAS2.06 ± 0.0342.181.96 ± 0.0438.44
ECAP-M72L1.68 ± 0.1034.311.45 ± 0.1128.33
ECAP-M72T1.44 ± 0.0529.361.81 ± 0.1435.37
ECAP-M72Q1.32 ± 0.0726.952.00 ± 0.0839.16
ECAP-M72W1.19 ± 0.0124.371.41 ± 0.0427.54
ECAP-M72V1.10 ± 0.0822.570.86 ± 0.0316.76
ECAP-M72I1.02 ± 0.0920.921.35 ± 0.1426.51
ECAP-M72A0.92 ± 0.0318.811.23 ± 0.1224.19
ECAP-M72S0.69 ± 0.0414.200.55 ± 0.0310.76
ECAP-M72P0.54 ± 0.0211.070.55 ± 0.0410.72
ECAP-M72C0.49 ± 0.0110.070.76 ± 0.0214.87
ECAP-M72H0.36 ± 0.047.390.43 ± 0.018.45
ECAP-M72N0.28 ± 0.035.730.40 ± 0.027.91
ECAP-M72Y0.26 ± 0.045.220.69 ± 0.0413.49
ECAP-M72F0.25 ± 0.045.170.22 ± 0.014.39
ECAP-M72D0.25 ± 0.035.020.32 ± 0.016.31
ECAP-M72E0.15 ± 0.023.100.17 ± 0.013.39
ECAP-M72K0.09 ± 0.031.870.12 ± 0.002.34
ECAP-M72G0.08 ± 0.031.650.10 ± 0.011.86
ECAP-M72R0.05 ± 0.021.000.05 ± 0.001.00

Paired t-test was applied to the comparison of relative values of activity ratios to ECAP between two lysis methods, giving t = 1.496, P = 0.15.

Relative value was derived as the activity ratio to that of M72R.

Table 4

Association of activity ratios in cell lysates of the fused forms with specific activities of their non-fused counterparts based on ITA.

MutantsSpecific activity by ITA (kU/g)Relative valueaLog10(Specific activity by ITA)log10 (Relative value)
ECAP-PAAS14.6054.361.161.74
ECAP-M72L8.3535.370.921.55
ECAP-M72T8.1839.160.911.59
ECAP-M72Q7.1028.330.851.45
ECAP-M72W7.0726.520.851.42
ECAP-M72V5.0627.550.701.44
ECAP-M72A4.9224.190.691.38
ECAP-M72I4.9616.760.701.22
ECAP-M72S3.6814.870.571.17
ECAP-M72C3.4610.760.541.03
ECAP-M72P3.6013.490.561.13
ECAP-M72H2.4110.720.381.03
ECAP-M72Y1.058.450.020.93
ECAP-M72D1.847.910.270.90
ECAP-M72E0.456.31−0.340.80
ECAP-M72N1.424.390.150.64
ECAP-M72G1.183.400.070.53
ECAP-M72F0.312.34−0.500.37
ECAP-M72K0.591.86−0.230.27
ECAP-M72R0.121.00−0.930.00

Relative value was derived as the activity ratio to that of M72R.

Table 5

Association of activity ratios in cell lysates of the fused forms with specific activities of their non-fused counterparts after affinity purification.

Activity of non-fused PAAS/mutant
Activity by SSA of ECAP-PAAS/mutantc
Activity by SDESA of ECAP-PAAS/mutantd
Specific activity (kU/g)Relative valuebActivity RatioaRelative valuebActivity RatioaRelative valueb
PAAS14.0912.36.2411.35.2012.8
M72Q4.704.12.053.71.603.9
G138S3.162.81.122.00.781.9
M72D1.151.00.550.4051.0

Activities were determined by SSA/SDESA, with proteins quantified by the Bradford method, activity ratio was the activity of PAAS/mutant to that of ECAP in their fused form.

Relative value was derived as the ratio to that ofM72D in the non-fused or fused form.

SSA indicates separate single assay, one-by-one, in two solution.

SDESA indicates spectrophotometric-dual-enzyme-simultaneous-assay.

Table 6

Activities and activity ratios in cell lysates of tested PAAS/mutants in fused forms by either SSA or SDESA.

Activity by SSA of ECAP -PAAS/mutantsc (n = 120)
Activity by SDESA of ECAP -PAAS/mutantsd (n = 120)
Activity on 4NPS (kU/g)Activity on 4NNPP (kU/g)Activity RatioaRelative valuebActivity on 4NPS (kU/g)Activity on 4NNPP (kU/g)Activity RatioaRelative valueb
ECAP-PAAS
Mean0.0240.0046.23711.30.0200.0045.20112.8
SD0.0060.0011.2290.0040.0011.041
cv23%19%20%21%18%20%
ECAP-M72Q
Mean0.0140.0072.0523.70.0100.00651.6003.9
SD0.0050.0020.3220.0040.0020.232
cv35%27%16%35%29%15%
ECAP-G138S
Mean0.0090.0081.1172.00.0070.0080.7801.9
SD0.0030.0030.2280.0020.0030.129
cv33%41%20%34%31%17%
ECAP-M72D
mean0.0060.0110.5531.00.0040.0100.4051.0
SD0.0010.0030.0790.0010.0030.053
cv19%27%14%21%28%13%

Activities were determined by SSA/SDESA, with proteins quantified by Bradford method, activity ratio was the activity of PAAS/mutant to that of ECAP in their fused form.

Relative value was derived as the ratio to that of M72D in fused form.

SSA indicates separate single assay, one-by-one, in two solution.

SDESA indicates spectrophotometric-dual-enzyme-simultaneous-assay.

Table 7

One-way ANOVA for statistical analysis of activity ratios determined in HTP mode for paired fused PAAS/mutants.

ECAP-G138S
ECAP-M72Q
ANOVA Result of 4PNS/4NNPP between SSA and SDESA
ANOVA Result of 4PNS/4NNPP ratio to M72D between SSA and SDESA
ANOVA Result of 4PNS/4NNPP between SSA and SDESA
ANOVA Result of 4PNS/4NNPP ratio to M72D between SSA and SDESA
Between GroupsWithin GroupsTotalBetween GroupsWithin GroupsTotalBetween GroupsWithin GroupsTotalBetween GroupsWithin GroupsTotal
Sum of Squares6.3167.53613.8520.52929.85430.38312.2318.74930.9793.3379.42682.756
df1220221122022112382391238239
Mean Squares6.3160.0340.5290.13612.230.0793.330.334
F184.373.895155.2519.978
Sig.
0.000


0.050


0.000


0.002



ECAP-PAAS
ECAP-M72D
ANOVA Result of 4PNS/4NNPP between SSA and SDESA
ANOVA Result of 4PNS/4NNPP ratio to M72D between SSA and SDESA
ANOVA Result of 4PNS/4NNPP between SSA and SDESA
ANOVA Result of 4PNS/4NNPP ratio to M72D between SSA and SDESA
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Sum of Squares60.137287.826347.963133.7311280.6261414.3571.2060.992.19504.1144.114
df1222223122222312202211220221
Mean Squares60.1371.297133.7315.7691.2060.00400.019
F46.38423.183268.0290
Sig.0.0000.0000.0000.993

SSA: separate single assay. SDESA: spectrophotometric-dual-enzyme-simultaneous-assay.

Fig. 5

ROC analyses of the recognition of hits in fused PAAS versus fused M72Q.

Scheme. 1

The expression vector map and active proteolytic fragments of fused forms. (a) The expression vector map. (b) Active proteolytic fragments of fused forms.

Three designed linkers for fusion expression of ECAP and PAAS. PAGE analyses of fragmentation patterns. Based on the Western blotting with polyclonal antibodies against PAAS, ECAP, monoclonal antibody against 6His tag, and Coomassie Blue R250 staining of polypeptides after SDS-PAGE in Fig. 1a, b, c, d in Ref. [1], respectively, here are the detection of polypeptides after separation by PAGE. (a) Coomassie Blue R250 staining. (b) ECAP activity staining with 1-Naphthol phosphate. (c) PAAS activity staining with 4-Nitrophenylsulfate on the same gel used in (b) after staining of ECAP activities. Distributions of PAAS mutants after saturation mutagenesis at M72. * represents the three termination codes. Association of activity ratios of the fused forms in cell lysates with specific activities of their purified non-fused counterparts. Thresholds of ECAP activities in cell lysates. Data for 140 individual clones transformed with the blank plasmid. Activity ratio was the activity of PAAS/mutant to that of ECAP in their fused form. Activity ratios of three fused forms via different linkers. Activities were determined by SSA/SDESA, with proteins quantified by Bradford method, activity ratio was the activity of PAAS/mutant to that of ECAP in their fused form. SSA indicates separate single assay, one-by-one, in two solution. SDESA indicates spectrophotometric-dual-enzyme-simultaneous-assay. Comparison of two methods for cell lysis. Paired t-test was applied to the comparison of relative values of activity ratios to ECAP between two lysis methods, giving t = 1.496, P = 0.15. Relative value was derived as the activity ratio to that of M72R. Association of activity ratios in cell lysates of the fused forms with specific activities of their non-fused counterparts based on ITA. Relative value was derived as the activity ratio to that of M72R. Association of activity ratios in cell lysates of the fused forms with specific activities of their non-fused counterparts after affinity purification. Activities were determined by SSA/SDESA, with proteins quantified by the Bradford method, activity ratio was the activity of PAAS/mutant to that of ECAP in their fused form. Relative value was derived as the ratio to that ofM72D in the non-fused or fused form. SSA indicates separate single assay, one-by-one, in two solution. SDESA indicates spectrophotometric-dual-enzyme-simultaneous-assay. Activities and activity ratios in cell lysates of tested PAAS/mutants in fused forms by either SSA or SDESA. Activities were determined by SSA/SDESA, with proteins quantified by Bradford method, activity ratio was the activity of PAAS/mutant to that of ECAP in their fused form. Relative value was derived as the ratio to that of M72D in fused form. SSA indicates separate single assay, one-by-one, in two solution. SDESA indicates spectrophotometric-dual-enzyme-simultaneous-assay. One-way ANOVA for statistical analysis of activity ratios determined in HTP mode for paired fused PAAS/mutants. SSA: separate single assay. SDESA: spectrophotometric-dual-enzyme-simultaneous-assay. ROC analyses of the recognition of hits in fused PAAS versus fused M72Q. The expression vector map and active proteolytic fragments of fused forms. (a) The expression vector map. (b) Active proteolytic fragments of fused forms. The lane of the same label in figures stood for the same sample, as follows. M: molecular weight markers; 0. Transformed with empty plasmid; 1. Purified ECAP; 2. Purified PAAS; 3. Purified ECAP-dHis-PAAS; 4. Purified ECAP-LHis-PAAS; 5. Purified ECAP-LL-PAAS; 6. ECAP-dHis-PAAS in lysate; 7. ECAP-LHis-PAAS in lysate; 8. ECAP-LL-PAAS in lysate.

Experimental design, materials and methods

Experimental design

The comparison of the activity ratios of an applicable enzyme and its mutants to a suitable enzyme tag in cell lysates of their fused forms for HTP screening of mutants requires both the negligible or consistent impacts of the enzyme tag on the activities of enzyme/mutants and the proportionality of the activities of the enzyme tag in cell lysates of the fused enzyme/mutants to protein quantities of the active forms of the fused enzyme/mutants in both their native and partially-fragmented fused states. With ECAP as the tag fused to the N-terminus of PAAS and its mutants via a flexible linker, the proposed strategy was tested.

Materials and methods

For each fused enzyme/mutant, an individual clone was transferred into 0.50 mL LB medium in 48-well microplate for amplification in 12 h at 37 °C and 180 rpm till optical density of 0.4–0.6 at 600 nm. Afterwards, each enzyme/mutant was induced for expression with 1.0 mM IPTG for 21 h at 15 °C. The lysates of fused mutants were prepared through alkaline lysis, unless otherwise stated. In detail, cell suspension of 20 μL from a well was transferred to a new well for mixing with 180 μL of the alkaline lysis buffer (1.0 M Tris-HCl at pH 9.0, plus 1.0 mM PMSF and 2.5 mM 4-aminobenzamidine) in 96-well microplates; the resulting mixture was agitated rapidly on Qilinbeier QB-9001 agitator for 4 h at room temperature to yield a cell lysate. The substrate solution containing 2.0 mM 4NPS and/or 0.20 mM 4NNPP was utilized to monitor the absorbance change at 405 and/or 450 nm (The substrate solution containing both substrates was utilized for spectrophotometric-dual-enzyme-simultaneous-assay (SDESA) of ECAP and PAAS/mutant [2,3]). For HTP assay of enzyme activity(ies), cell lysate of 20 μL was mixed with a substrate solution of 180 μL in 96-well microplates. The mixtures in wells were agitated for 2.0 min at room tempearture; after a total lagging time of 4.0 min, the absorbance of each well was recorded in 30 min at room tempearture to estimate initial rate for enzyme activity by linear regression with the preset absorptivity of 12 (mmol)−1·L−1·cm−1 for 4-nitrophenol and 19 (mmol)−1·L−1·cm−1 for 4-nitro-1-naphthol considering the light path. The change of absorbance of no less than 0.003 in 10 min was taken as the detection limit of enzyme activity, after the correction of the overlapped absorbance of chromogenic products during SDESA. The activity ratio of PAAS/mutant to ECAP was the percentage of PAAS/mutant activity on 4NPS to ECAP activity on 4NNPP. Receiver-operating-characteristic (ROC) analysis yielded the area-under-the-curve (AUC) for the recognition of the one of higher activity in a pair.

Specifications Table

SubjectChemistry, Biology
Specific subject areaBiomolecule engineering
Type of dataFigure, Table
How data were acquiredThe adsorbance change for enzyme activity assay was recorded with Biotek ELX 800 at room temperature.
Data formatRaw and Analyzed
Parameters for data collectionThe mixture of cell lysate of 20 μL and substrate of 180 μL containing both or one of final 2.0 mM 4NPS and final 0.20 mM 4NNPP in a well was agitated for 2.0 min at room temperature, to record the absorbance in 30 min after the total lagging time of 4.0 min.
Description of data collectionFusion expression of ECAP with PAAS and its mutants in DE3; Protein bands after SDS-PAGE staining with Coomassie brilliant blue or antibodies following standard protocol; SDESA or separate single assay of ECAP and PAAS/mutant to derive their activity ratios.
Data source locationChongqing Medical University, Chongqing 400016, China
Data accessibilityData incorporated within this article
Related research articleYaping Li, Huimin Chong, Xiang Zhang, Xiaolan Yang,*, Fei Liao*High-throughput screening of enzyme mutants by comparison of their activity ratios to an enzyme tagAnalytical Biochemistry doi: 10.1016/j.ab.2019.113474
Value of the Data

The dataset in this report will facilitate understanding the validation and application of a new high-throughput screening strategy to mutants of an enzyme in a library [1]. To recognize positive mutants in a library, this new screening strategy fuses enzyme/mutants with a tag enzyme to compare activity ratios of the enzyme/mutants to the tag enzyme in cell lysates of their fused forms, when such activity ratios have physical significance and are proportional to specific activities of the non-fused counterpart enzyme/mutants.

Re-analyses of these data will benefit researchers to develop a practical system of the new high-throughput screening strategy for directed evolution of an applicable enzyme.

The data in this report utilizes Escherichia coli alkaline phosphatase (ECAP) as the tag enzyme for fusion with Pseudomonas Aeruginosa arylsulfatase (PAAS) via a flexible linker. Through the analyses of the data of the activities of ECAP in lysates of both Escherichia coli BL21 (DE3) transformed with a blank plasmid and host cells transformed with the fused mutants of PAAS, a rational threshold of ECAP activities in cell lysates can be developed for physical significance of the activity ratios of their fused forms at a preset confidence limit. Meanwhile, with a focused library of PAAS mutants through saturated mutagenesis at M72, the data enable researchers to understand the proportionality between the activity ratios of PAAS/mutants to ECAP in cell lysates of their fused forms and specific activities of the non-fused counterpart PAAS/mutants.

The data in this report will provide insights on the application of the new screening strategy to the elucidation of sequence-activity relationship of an applicable enzyme.

  3 in total

1.  High-throughput screening of enzyme mutants by comparison of their activity ratios to an enzyme tag.

Authors:  Yaping Li; Huimin Chong; Xiang Zhang; Xiaolan Yang; Fei Liao
Journal:  Anal Biochem       Date:  2019-10-12       Impact factor: 3.365

2.  Spectrophotometric-dual-enzyme-simultaneous assay in one reaction solution: chemometrics and experimental models.

Authors:  Hongbo Liu; Xiaolan Yang; Lin Liu; Jizheng Dang; Yanling Xie; Yi Zhang; Jun Pu; Gaobo Long; Yuanli Li; Yonghua Yuan; Juan Liao; Fei Liao
Journal:  Anal Chem       Date:  2013-01-25       Impact factor: 6.986

3.  Comparison of Candidate Pairs of Hydrolytic Enzymes for Spectrophotometric-dual-enzyme-simultaneous-assay.

Authors:  Hongbo Liu; Mei Yuan; Xiaolan Yang; Xiaolei Hu; Juan Liao; Jizheng Dang; Yanling Xie; Jun Pu; Yuanli Li; Chang-Guo Zhan; Fei Liao
Journal:  Anal Sci       Date:  2015       Impact factor: 2.081

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.